SCHEMBL13055591

SCHEMBL13055591

CC1(C)c2cc3cc(-c4ccc5ccccc5c4)ccc3cc2-c2cc3ccc(N(c4ccc5ccccc5c4)c4ccc5ccccc5c4)cc3cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
GSTP1 P09211 1/20 0.38
ALOX5 P09917 1/20 0.37
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
PTGER3 P43115 3/20 0.35
ACMSD Q8TDX5 1/20 0.35
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
RARA P10276 1/20 0.34
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19197010 0.94 HTT (0.35) GSTP1ALDH1A1CA1CA2CYP1A2
SCHEMBL13055625 0.94 HTT (0.35) GSTP1ALDH1A1CA1CA2CYP1A2
SCHEMBL19197481 0.92 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EMAPTCYP1A2
SCHEMBL23597919 0.90 LPL (0.36) LPLLIPGESR1ESR2GSTP1
SCHEMBL23598003 0.90 LPL (0.36) LPLLIPGESR1ESR2GSTP1
SCHEMBL23597918 0.90 PDK2 (0.36) LPLLIPGESR1ESR2GSTP1
SCHEMBL19197396 0.90 PTGS2 (0.35) LPLLIPGESR1ESR2GSTP1
SCHEMBL19197009 0.90 PTGS2 (0.35) LPLLIPGESR1ESR2GSTP1
SCHEMBL13341817 0.90 ALDH1A1 (0.38) ALDH1A1KDM4ELMNAMAPTCYP1A2
SCHEMBL22739812 0.89 PTGS2 (0.34) LPLLIPGESR1ESR2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838130-B2 Aminodibenzofluorene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-23 US disclosed
US-7838130-B2 Aminodibenzofluorene derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-23 US disclosed
US-20090267491-A1 AMINODIBENZOFLUORENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-10-29 US disclosed
US-20090267491-A1 AMINODIBENZOFLUORENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090267491-A1 AMINODIBENZOFLUORENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME L1CAM, DDC, LEF1 LPL 856/4885LIPG 817/4885ESR1 370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.